Cargando…

The Role of Barrier Dysfunction and Change of Claudin Expression in Inflammatory Bowel Disease

Detalles Bibliográficos
Autor principal:	Kim, Tae Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625696/ https://www.ncbi.nlm.nih.gov/pubmed/26503569 http://dx.doi.org/10.5009/gnl15430

Ejemplares similares

Claudin may be a Potential Biomarker for Epithelial Barrier Dysfunction in Asthma
por: Jin, Hyun Jung, et al.
Publicado: (2018)

Complexity and developmental changes in the expression pattern of claudins at the blood–CSF barrier
por: Kratzer, Ingrid, et al.
Publicado: (2012)

Dietary role in the development and treatment of inflammatory bowel disease
por: Kim, Jae Young
Publicado: (2020)

Inflammatory Bowel Disease: Changing Associations to Mechanisms
por: Click, Benjamin, et al.
Publicado: (2016)

What Are the Major Changes in Korean Inflammatory Bowel Disease Surgery?
por: Kim, Chang-Nam
Publicado: (2018)

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases
por: Lee, Jessica Y., et al.
Publicado: (2018)

Role of new endoscopic techniques in inflammatory bowel disease management: Has the change come?
por: Goran, Loredana, et al.
Publicado: (2017)

Unraveling a New Role for Claudins in Gastric Tumorigenesis
por: Hagen, Susan J.
Publicado: (2019)

Claudin Family Participates in the Pathogenesis of Inflammatory Bowel Diseases and Colitis-Associated Colorectal Cancer
por: Zhu, Liguo, et al.
Publicado: (2019)

Intestinal Barrier, Claudins and Mycotoxins
por: Kozieł, Marta Justyna, et al.
Publicado: (2021)

Deciphering the Role of Mesenteric Fat in Inflammatory Bowel Disease
por: Gewirtz, Andrew T.
Publicado: (2015)

Role of NLRP3 inflammasome in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2019)

IL-21 mediates microRNA-423-5p /claudin-5 signal pathway and intestinal barrier function in inflammatory bowel disease
por: Wang, Mu, et al.
Publicado: (2020)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Butyrate Alleviates Cytokine-Induced Barrier Dysfunction by Modifying Claudin-2 Levels
por: Huang, Xinyi, et al.
Publicado: (2021)

Addressing Sexual Dysfunction in Patients with Inflammatory Bowel Disease—We Can Do Better
por: Clarke, Kofi
Publicado: (2020)

Sexual Dysfunction and Fertility Problems in Men with Inflammatory Bowel Disease
por: Park, Yong Eun, et al.
Publicado: (2020)

Claudin18.who? Examining biomarker overlap and outcomes in claudin18.2-positive gastroesophageal adenocarcinomas
por: Klempner, S.J., et al.
Publicado: (2023)

The Mental Health State of Quiescent Inflammatory Bowel Disease Patients
por: Park, Sung Chul, et al.
Publicado: (2016)

Predictive Significance of Claudin-3 for Epithelial Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps
por: Huang, Zhi-Qun, et al.
Publicado: (2023)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Poly(I:C) Induces Human Lung Endothelial Barrier Dysfunction by Disrupting Tight Junction Expression of Claudin-5
por: Huang, Li-Yun, et al.
Publicado: (2016)

Tight Junction barriers in human hair follicles – role of claudin-1
por: Zorn-Kruppa, Michaela, et al.
Publicado: (2018)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer
por: Kłos, Patrycja, et al.
Publicado: (2021)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study
por: Arpa, Giovanni, et al.
Publicado: (2022)

Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
por: Eun, Chang Soo
Publicado: (2017)

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?
por: Park, Jihye
Publicado: (2023)

Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
por: Kim, Young-Ho
Publicado: (2018)

Mitochondrial dysfunction in inflammatory bowel disease
por: Novak, Elizabeth A., et al.
Publicado: (2015)

Differential regulation of claudin-2 and claudin-15 expression in children and adults with malabsorptive disease
por: Ong, M. Lora D. M., et al.
Publicado: (2019)

Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
por: Kiesslich, R, et al.
Publicado: (2011)

Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease
por: Al-Shaibi, Ahmad A., et al.
Publicado: (2021)

E-cadherin activating antibodies limit barrier dysfunction and inflammation in mouse inflammatory bowel disease
por: Bandyopadhyay, Chirosree, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b5uhe4eokajj9r6sju75ml59ev